CALDWELL INVESTMENTS PLC
28 October 1999
Results of Rights Issue
The Board of Caldwell Investments plc announces that valid acceptances in
relation to the Rights Issue have been received in respect of 2,194,353 new
ordinary shares representing 79.58 per cent of the 2,757,500 new ordinary
shares offered by way of rights at 25p per share. All Directors have taken up
their full entitlements under the Rights Issue.
The balance of the Rights Issue, being 563,147 new ordinary shares, has today
been placed by Charles Stanley & Company Limited with certain subscribers at a
price of 37.5p per share, a premium of 12.5p per share over the Rights Issue
price.
The premium over the Rights Issue price (after deducting the expenses of
procuring subscribers) will be paid pro-rata to provisional allottees
originally entitled thereto, except that amounts less than £3.00 will not be
so paid but will be retained for the benefit of the Company.
Enquiries:
S Wootliff Tel: 01132 350 632
Not for release, publication or distribution in or into the United States of
America, Canada, Japan, Australia or the Republic of Ireland.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.